Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 6/2006

01-11-2006 | Original Paper

Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City

Authors: Judith Absalon, Crystal M. Fuller, Danielle C. Ompad, Shannon Blaney, Beryl Koblin, Sandro Galea, David Vlahov

Published in: AIDS and Behavior | Issue 6/2006

Login to get access

Abstract

We compared sexual behaviors/partnerships and determined sexual risk correlates associated with HIV by gender among street-recruited drug users using chi-square tests and logistic regression. Men reported higher risk sexual behaviors, yet fewer high-risk sexual partners than women. After adjustment, HIV seropositive men were more likely than seronegatives to be older, MSM, use condoms, and have an HIV-infected partner. HIV seropositive women were more likely to be older, have an HIV-infected partner, and not use non-injected heroin. IDU was not associated with HIV. Prospective studies are needed to determine how gender-specific sexual behaviors/partnerships among drug users affect HIV acquisition.
Literature
Absalon, J., Della Latta, P., Wu, F., and El-Sadr, W. (2005). Sexual behaviors and condom use of HIV-infected men and women of color attending a treatment and care clinic. Journal of the National Medical Association, 97(7), 25S–31S.PubMed
Anthony, J. C., Vlahov, D., Celentano, D., Menon, A. S., Margolick, J., Cohn, S., et al. (1991). Self-report interview data for a study of HIV-1 infection among intravenous drug users: Description of methods and preliminary evidence on validity. The Journal of Drug Issues, 21(4), 739–757.
Chitwood, D. D., Comerford, M., and Sanchez, J. (2003). Prevalence and risk factors for HIV among sniffers, short-term injectors, and long-term injectors of heroin. Journal of Psychoactive Drugs, 35(4), 445–453.PubMed
Des Jarlais, D. C., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., et al. (2000). HIV incidence among injection drug users in New York City, 1992–1997: Evidence for a declining epidemic. American Journal of Public Health, 90(3), 352–359.PubMedCrossRef
Department of Health and Human Services. (2003). Drug abuse warning network, emergency department trends, final estimates 1995–2002. Retrieved 2005, from http://​www.​dawninfo.​samhsa.​gov
Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B., Word, C., Serrano, Y., et al. (1994). Intersecting epidemics–crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. New England Journal of Medicine, 331(21), 1422–1427.PubMedCrossRef
Fuller, C. M., Absalon, J., Ompad, D. C., Nash, D., Koblin, B., Blaney, S., et al. (2005). A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000–2003. Journal of Urban Health, Mar 82(Suppl 1), i51–i61.
Fuller, C. M., Vlahov, D., Latkin, C. A., Ompad, D. C., Celentano, D. D., and Strathdee, S. A. (2003). Social circumstances of initiation of injection drug use and early shooting gallery attendance: Implications for HIV intervention among adolescent and young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes, 32(1), 86–93.PubMed
Kalichman, S., and Roffman, R. A. (1998). Risk for HIV infection among bisexual men seeking HIV prevention services and risks posed to their female partners. Health Psychology, 17(4), 320–327.PubMedCrossRef
Latkin, C. A., Mandell, W., and Vlahov, D. (1996). The relationship between risk networks’ patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: A prospective study. Drug and Alcohol Dependence, 42(3), 175–181.PubMedCrossRef
Ompad, D. C., Fuller, C. M., Galea, S., Del Vecchio, S., and Vlahov, D. (2004a). HIV risk behaviors among young female drug users who have sex with women in New York City. Oral Presentation. Paper presented at the XV International Conference on AIDS, Bangkok, Thailand.
Ompad, D. C., Fuller, C. M., Galea, S., Wu, Y., Nash, D., Benjamin, E., et al. (2004b). Sexual risk is associated with HIV among injection and non-injection drug users: Implications for intervention strategies. Paper presented at the XV International Conference on AIDS, Bangkok, Thailand.
Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., et al. (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndromes, 30 (Suppl 1), S73–S93.PubMed
Semple, S., Patterson, T., and Grant, I. (2002). Gender differences in the sexual practices of HIV+ heterosexual men and women. AIDS and Behavior, 6(1), 45–54.CrossRef
Solorio, R., Swendeman, D., and Rotheram-Borus, M. J. (2003). Risk among young gay and bisexual men living with HIV. AIDS Education and Prevention, 15(Suppl A), 80–89.PubMedCrossRef
Metadata
Title
Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City
Authors
Judith Absalon
Crystal M. Fuller
Danielle C. Ompad
Shannon Blaney
Beryl Koblin
Sandro Galea
David Vlahov
Publication date
01-11-2006
Published in
AIDS and Behavior / Issue 6/2006
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-006-9082-x

Other articles of this Issue 6/2006

AIDS and Behavior 6/2006 Go to the issue

Original Artical

Inconsistent Condom Use with Steady and Casual Partners and Associated Factors among Sexually-Active Men who Have Sex with Men in Bangkok, Thailand

Original Article

New York City Injection Drug Users’ Memories of Syringe-Sharing Patterns and Changes During the Peak of the HIV/AIDS Epidemic

Original Paper

Improving Dietary Habits in Disadvantaged Women With HIV/AIDS: The SMART/EST Women's Project

Original Paper

Examining the role of partner status in an HIV prevention trial targeting HIV-positive gay and bisexual men: the seropositive urban men’s intervention trial (SUMIT)

Original Paper

A Controlled Study of an HIV/AIDS/STI/TB Intervention with Traditional Healers in KwaZulu-Natal, South Africa

Original Article

Assessing the Efficacy of a Voluntary HIV Counseling and Testing Intervention for Pregnant Women and Male Partners in Urumqi City, China
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits